Aytu Bioscience (AYTU), iBio (IBIO) & Vaxart (VXRT) rockets on Russell Index addition

Shares of Aytu Bioscience (AYTU), iBio (IBIO) & Vaxart (VXRT) has seen tremendous growth for the past couple day as their Russell Index addition nears fruition.

On Monday, June 29, the three companies are set to join the Russell Index, FTSE Russell is a global index provider that makes available a comprehensive range of indexes used by investors to measure and analyze global markets.

FTSE Russell is a leading global index provider creating and managing a wide range of indexes, data and analytic solutions to meet client needs across asset classes, style and strategies. Covering 98% of the investable market, FTSE Russell indexes offer a true picture of global markets, combined with the specialist knowledge gained from developing local benchmarks around the world.

FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately $16 trillion is currently benchmarked to FTSE Russell indexes. For over 30 years, leading asset owners, asset managers, ETF providers and investment banks have chosen FTSE Russell indexes to benchmark their investment performance and create investment funds, ETFs, structured products and index-based derivatives. FTSE Russell indexes also provide clients with tools for asset allocation, investment strategy analysis and risk management.

A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on index innovation and customer partnership applying the highest industry standards and embracing the IOSCO Principles. FTSE Russell is wholly owned by London Stock Exchange Group.

Why the addition of Aytu Bioscience (AYTU), iBio (IBIO) & Vaxart (VXRT) is a big deal

The addition of these stocks are a huge deal because now AYTU, IBIO & VXRT will gain publicity and with that huge gains will follow from institutional investors and hedge funds.

Tim Rolle
Tim Rolle

Investor of 6 years and Managing Editor of Money Midnight, a news outlet focused on highly profitable investment ideas and bold underground research.

Articles: 117

Newsletter Updates

Enter your email address below to subscribe to our newsletter